✦ LIBER ✦

6-Imino-2-thioxo-pyrimidinones as a new class of dipeptidyl peptidase IV inhibitors

✍ Scribed by Dubravko Jelić; Krunoslav Nujić; Višnja Stepanić; Krunoslav Kovačević; Donatella Verbanac

Book ID: 105771075
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 366 KB
Volume: 20
Category: Article
ISSN: 1054-2523
DOI: 10.1007/s00044-010-9314-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl peptidase-IV inhibitors: a ma

Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug

✍ Iskandar Idris; Richard Donnelly 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

ChemInform Abstract: 2-Cyanopyrrolidides

ChemInform Abstract: 2-Cyanopyrrolidides as Potent, Stable Inhibitors of Dipeptidyl Peptidase IV

✍ D. M. ASHWORTH; B. ATRASH; G. R. BAKER; A. J. BAXTER; P. D. JENKINS; D. M. JONES 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB

Dipeptidyl peptidase IV inhibitors as ne

Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes

✍ Augustyns, Koen; Van der Veken, Pieter; Senten, Kristel; Haemers, Achiel 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 189 KB

Dipeptidyl peptidase IV (DPP IV) inhibit

Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.

✍ Green, Brian D; Flatt, Peter R; Bailey, Clifford J 📂 Article 📅 2006 🏛 International Society of Diabetes and Vascular Dis 🌐 English ⚖ 120 KB

Dipeptidyl peptidase IV inhibitors: A pr

Dipeptidyl peptidase IV inhibitors: A promising new therapeutic approach for the management of type 2 diabetes

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Discovery of new chemotype dipeptidyl pe

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore

✍ Yukihiro Nishio; Hidenori Kimura; Shinya Tosaki; Eiji Sugaru; Mutsuko Sakai; Mas 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One of these compounds was found to have good oral bioavailability and PK/PD profile in ZF-rat.